Comparison of Two Pulmonary Embolism Treatments

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 27, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

October 31, 2026

Conditions
Pulmonary Embolism Acute
Interventions
DRUG

Anticoagulation

Anticoagulation with unfractionated heparin (UFH) or low molecular weight heparin (LMWH)

DEVICE

mechanical aspiration thrombectomy

Mechanical aspiration thrombectomy with the Indigo Aspiration System.

Trial Locations (22)

10029

Mount Sinai Hospital, New York

21201

University of Maryland, Baltimore

23507

Sentara Norfolk General Hospital, Norfolk

30033

Joseph Maxwell Cleland Atlanta VA Medical Center, Decatur

30060

Wellstar Kennestone, Marietta

33801

Radiology and Imaging Specialists/Lakeland Regional, Lakeland

41017

St. Elizabeth Edgewood Hospital, Edgewood

48073

Corewell Health William Beaumont University Hospital, Royal Oak

48708

McLaren Bay Heart & Vascular, Bay City

60611

Northwestern Memorial, Chicago

60612

Rush University Medical Center, Chicago

75226

Baylor University Medical Center, Dallas

77339

Kingwood Medical Center, Kingwood

78212

Metropolitan Methodist Hospital, San Antonio

78705

Ascension Seton Medical Center Austin, Austin

85719

The University of Arizona - Banner, Tucson

90024

UCLA Medical Center, Los Angeles

90048

Cedars Sinai Medical Center, Los Angeles

08103

Cooper Health System, Camden

T2N 2T9

Foothills Medical Centre, Calgary

Unknown

Auckland City Hospital, Auckland

Krakowski Szpital Specjalistyczny św. Jana Pawła II, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Penumbra Inc.

INDUSTRY

NCT05684796 - Comparison of Two Pulmonary Embolism Treatments | Biotech Hunter | Biotech Hunter